Refractory/Relapsed B-cell Lymphoma
1 clinical trials · Condition
◉ Watch Refractory/Relapsed B-cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Clinical Study of Oncolytic Vaccinia VIrus Delivering Targeted CD19 in Vivo CAR-T/M Therapy for Refractory/Relapsed B-cell Lymphoma (NCT07398963) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-02-01 |
Track Refractory/Relapsed B-cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.